We create public awareness and education, advocate to shape equitable science-driven legislation and health policies, and advance research for rare autoimmune optic nerve diseases.

We leverage public and private partnerships to catalyze change in the lives of those affected by rare autoimmune optic nerve diseases. These diseases include NMOSD, MOGAD, Inflammatory Optic Neuropathy, Antibody-Mediated Optic Neuritis, Idiopathic Optic Neuritis, and Seronegative Optic Neuritis.

We create programs to advance research, public awareness, and education for rare autoimmune optic nerve diseases.

We impact the lives of rare autoimmune optic nerve disease patients and their caregivers by advocating for equitable public health policies that support timely diagnoses, effective treatments, and pioneering cures.

We advance treatments by funding scientific research and public education campaigns to improve outcomes and transform the lives of those living with rare autoimmune optic nerve diseases.